Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9

Kidney International

Volumn 52, Issue 6, 1997, Pages 1570-1578

  Nangaku, Masaomi ^a   Alpers, Charles E ^b   Pippin, Jeff ^b   Shankland, Stuart J ^b   Kurokawa, Kiyoshi ^b   Adler, Stephen ^b   Johnson, Richard J ^b   Couser, William G ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

C5b 9 and endothelial injury; Injury and complement cascade; Thrombotic microangiopathy

Indexed keywords

COMPLEMENT COMPONENT C5B;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; COMPLEMENT ACTIVATION; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; GLOMERULUS BASEMENT MEMBRANE; KIDNEY INJURY; MICROANGIOPATHY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; XENOTRANSPLANTATION;

EID: 0031434610     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.487     Document Type: Article

References (88)

1. COUSER WG: The pathogenesis of glomerulonephritis. Kidney Int 44(Suppl 42):S19-S26, 1993
2. COUSER WG: Mediation of immune glomerular injury. J Am Soc Nephrol 1:13-29, 1990
3. YAMAMOTO T, WILSON CB: Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney Int 32:514-525, 1987
4. YAMAMOTO T, WILSON CB: Complement dependence of antibody-induced mesangial cell injury in the rat. J Immunol 138:3758-3765, 1987
5. SALANT DJ, BELOK S, MADAIO MP, COUSER WG: A new role for complement in experimental membranous nephropathy in rats. J Clin Invest 66:1339-1350, 1980
6. JOHNSON RJ, PRITZL P, IIDA H, ALPERS CE: Platelet-complement interactions in mesangial proliferative nephritis in the rat. Am J Pathol 138:313-321, 1991
7. BRANDT J, PIPPIN J, SCHULZE M, HÄNSCH GM, ALPERS CE, JOHNSON RJ, GORDON K, COUSER WG: Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int 49:335-343, 1996
8. CYBULSKY AV, QUIGG RJ, SALANT DJ: The membrane attack complex in complement-mediated glomerular epithelial cell injury: Formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy. J Immunol 137:1511-1516, 1986
9. KERJASCHKI D, SCHULZE M, BINDER S, KAIN R, OJHA PP, SUSANI M, HORVAT R, BAKER PJ, COUSER WG: Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol 143:546-552, 1989
10. GROGGEL GC, ADLER S, RENNKE HG, COUSER WG: Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit. J Clin Invest 72:1948-1957, 1983
11. SAVIN VJ, JOHNSON RJ, COUSER WG: C5b-9 increases albumin permeability of isolated glomeruli in vitro. Kidney Int 46:382-387, 1994
12. BAKER PJ, OCHI RF, SCHULZE M, JOHNSON RJ, CAMPBELL C, COUSER WG: Depletion of C6 prevents development of proteinuria in experimental membranous nephropalhy in rats. Am J Pathol 135:185-194, 1989
13. CYBULSKY AV, RENNKE HG, FEINTZEIG ID, SALAM DJ: Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy. J Clin Invest 77: 1096-1107, 1986
14. HÄNSCH GM, BETZ M, GUNTHER J, ROTHER KO, STERZEL B: The complement membrane attack complex stimulates the prostanoid production of cultured glomerular epithelial cells. Int Arch Allergy Appl Immunol 85:87-93, 1988
15. HEBERT LA, COSIO FG, BIRMINGHAM DJ: The role of complement system in renal injury. Semin Nephrol 12:408-427, 1992
16. COUSER WG, SCHULZE M, PRUCHNO CJ: Role of C5b-9 in experimental membranous nephropathy. Nephrol Dial Transplant 7:S25-S31, 1992
17. SALANT DJ, QUIGG RJ, CYBULSKY AV: Heymann nephritis: Mechanisms of renal injury. Kidney Int 35:976-984, 1989
18. CYBULSKY AV, SALANT DJ, QUIGG RJ, BADALAMENTI J, BONVENTRE JV: Complement C5b-9 complex activates phospholipases in glomerular epithelial cells. Am J Physiol 257:F826-F836, 1989
19. QUIGG RJ, CYBULSKY AV, JACOBS JB, SALANT DJ: Anti-Fx1a produces complement-dependent cytotoxicity of glomerular epithelial cells. Kidney Int 34:43-52, 1988
20. FRAMPTON G, JAYNE DR, PERRY GJ, LOCKWOOD CM, CAMERON JS: Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 82:227-232, 1990
21. SAVAGE COS, POTTINGER B, GASKIN G, LOCKWOOD CM, PUSEY CD, PEARSON J: Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: Presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 85:14-19, 1991
22. MARKS RM, CZERNIECKI M, ANDREWS BS, PENNY R: The effects of scleroderma serum on human microvascular endothelial cells. Arthritis Rheum 31:1524-1534, 1988
23. DEL PAPA N, GAMBINI D, MERONI PL: Anti-endothelial antibodies and autoimmune diseases. Clin Rev Allergy 12:275-286, 1994
24. MERONI PL, D'CRUZ D, KHAMASHTA M, YOUINOU P, HUGHES GRV: Anti-endothelial cell antibodies: Only for scientists or for clinicians too? Clin Exp Immunol 104:199-202, 1996
25. CHAN TM, CHENG IKP: A prospective study on anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 78:41-46, 1996
26. D'CRUZ DP, HOUSSIAU FA, RAMIREZ G, BAGULEY E, MCCUTCHEON J, VIANNA J, HAGA H-J, SWANA GT, KHAMASHTA MA, TAYLOR JC, DAVIES DR, HUGHES GRV: Antibodies to endothelial cells in systemic lupus erythematosus: A potential marker for nephritis and vasculitis. Clin Exp Immunol 85:254-261, 1991
27. CINES DB, LYSS AP, REEBER M, BINA M, DEHORATIUS RJ: Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest 73:611-625, 1984
28. PERRY GJ, ELSTON T, KHOURI NA, CHAN TM, CAMERON JS, FRAMPTON G: Antiendothelial cell antibodies in lupus: Correlations with renal injury and circulating markers of endothelial damage. Q J Med 86:727-734, 1993
29. VAN DER ZEE JM, SIEGRT CEH, DE VREEDE TA, DAHA MR, BREEDVELD FC: Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus. Clin Exp Immunol 84:238-244, 1991
30. WANG MX, WALKER RG, KINCAID-SMITH P: Clinicopathologic associations with anti-endothelial cell antibodies in immunoglobulin A nephropathy and lupus nephritis. Am J Kidney Dis 22:378-386, 1993
31. MOAKE JL: Haemolytic-uraemic syndrome: Basic science. Lancet 343:393-397, 1994
32. LEUNG DYM, MOAKE JL, HAVENS PL, KIM M, POBER JS: Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome. Lancet 2:183-186, 1988
33. KOENIG DW, BARLEY-MALONEY L, DANIEL TO: A western blot assay detects autoantibodies to cryptic endothelial antigens in thrombotic microangiopathies. J Clin Immunol 13:204-211, 1993
34. KNIAZ D, EISENBERG GM, ELRAD H, JOHNSON CA, VALAITIS J, BREGMAN H: Postpartum hemolytic uremic syndrome associated with antiphospholipid antibodies. Am J Nephrol 12:126-133, 1992
35. FRYER JP, LEVENTHAL JR, MATAS AJ: The emergence of xenotransplantation. Transplant Immunol 3:21-31, 1995
36. PLATT JL: The immunological barriers to xenotransplantation. Crit Rev Immunol 16:331-358, 1996
37. ROBSON SC, CANDINAS D, HANCOCK WW, WRIGHTON C, WINKLER H, BACH FH: Role of endothelial cells in transplantation. Int Arch Allergy Immunol 106:305-322, 1995
38. NANGAKU M, ALPERS CE, PIPPIN J, SHANKLAND SJ, ADLER S, KUROKAWA K, COUSER WG, JOHNSON RJ: A new model of renal microvascular endothelial injury. Kidney Int 52:182-194, 1997
39. ALPERS CE, HUDKINS KL, PRITZL P, JOHNSON RJ: Mechanisms of clearance of immune complexes from peritubular capillaries in the rat. Am J Pathol 139:855-867, 1991
40. ADLER S, ENG B: Integrin receptors and function on cultured glomerular endothelial cells. Kidney Int 44:278-284, 1993
41. RUSSO C, CALLEGARO L, LANZA E, FERRONE S: Purification of IgG monoclonal antibody by caprylic acid precipitation. J Immunol Method 65:269-271, 1983
42. NANGAKU M, PIPPIN J, RICHARDSON CA, SCHULZE M, YOUNG BA, ALPERS CE, GORDON KL, JOHNSON RJ, COUSER WG: Beneficial effects of systemic immunoglobulin in experimental membranous nephropathy. Kidney Int 50:2054-2062, 1996
43. LEENAERTS PL, STAD RK, HALL M, VAN DAMME BJ, VAN-RENTERGHEM Y, DAHA MR: Hereditary C6 deficiency in a strain of PVG/c rats. Clin Exp Immunol 97:478-484, 1993
44. BAGCHUS WM, JEUNINK MF, ROZING J, ELEMA JD: A monoclonal antibody against rat platelets. I. Tissue distribution in vitro and in vivo. Clin Exp Immunol 75:317-323, 1989
45. DUIJVESTIJN AM, VAN GOOR H, KLATTER F, MAJOOR GD, VAN BUSSEL E, VAN BREDA VRIESMAN PJC: Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody. Lab Invest 66:459-466, 1992
46. DIAMOND JR, VAN GOOR H, DING G, ENGELMYER E: Myofibroblasts in experimental hydronephrosis. Am J Pathol 146:121-129, 1995
47. SCHULZE M, BAKER PJ, PERKINSON DT, JOHNSON RJ, OCHI RF, STAHL RAK, COUSER WG: Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat. Kidney Int 35:60-68, 1989
48. NELSON RA, JENSEN J, GIGLI I, TAMURA N: Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry 3:111-135, 1966
49. BRADLEY GM, BENSON ES: Examination of the urine, in Todd-Stanford. Clinical Diagnosis by Laboratory Methods, edited by DAVIDSOHN I, HENRY JB, 15th edition, Philadelphia, W.B. Saunders, 1974
50. MULLIGAN MS, SCHMID E, BECK-SCHIMMER B, TILL GO, FRIEDL HP, BRAUER RB, HUGLI TE, MIYASAKA M, WARNER RL, JOHNSON KJ, WARD PA: Requirement and role of C5a in acute lung inflammatory injury in rats. J Clin Invest 98:503-512, 1996
51. BRAUER RB, BALDWIN WM, DAHA MR, PRUITT SK, SANFILIPPO F: Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol 151:7240-7248, 1993
52. BRAUER RB, BALDWIN WM, IBRAHIM S, SANFILIPPO F: The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat. Transplantation 59:288-293, 1995
53. ADLER S, BAKER PJ, JOHNSON RJ, OCHI RF, PRITZL P, COUSER WG: Complement membrane attack complex stimulates production of oxygen metabolites by cultured rat mesangial cells. J Clin Invest 77:762-777, 1986
54. LOVETT DH, HÄNSCH G-M, GOPPELT M, RESCH K, GEMSA D: Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol 138:2473-2480, 1987
55. NANGAKU M, MEEK RL, PIPPIN J, GORDON KL, MORGAN BP, JOHNSON RJ, COUSER WG: Transfected CD59 protects mesangial cells from injury induced by antibody and complement. Kidney Int 50:257-266, 1996
56. NANGAKU M, QUIGG RJ, SHANKLAND SJ, OKADA N, JOHNSON RJ, COUSER WG: Overexpression of Crry protects mesangial cells from complement mediated injury. J Am Soc Nephrol 8:223-233, 1997
57. SCHONERMARK M, DEPPISCH R, RIEDASCH G, ROTHER K, HÄNSCH G-M: Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9. Int Arch Allergy Appl Immunol 96:331-337, 1991
58. WAGNER C, BRAUNGER M, BEER M, ROTHER K, HÄNSCH G-M: Induction of matrix protein synthesis in human glomerular mesangial cells by the terminal complement complex. Exp Nephrol 2:51-56, 1994
59. TORBOHM I, SCHONERMARK M, WINGEN A-M, BERGER B, ROTHER K, HÄNSCH G-M: C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells. Kidney Int 37:1098-1104, 1990
60. FRIES JW, MENDRICK DL, RENNKE HG: Determinants of immune complex-mediated glomerulonephritis. Kidney Int 34:333-345, 1988
61. GOLBUS M, WILSON CB: Experimental glomerulonephritis induced by in situ formation of immune complexes in glomerular capillary wall. Kidney Int 16:148-157, 1979
62. JOHNSON RJ, ALPERS CE, PRITZL P, SCULZE M, BAKER P, PRUCHNO C, COUSER WG: Platelets mediate neutrophil-dependent immune complex nephritis in the rat. J Clin Invest 82:1225-1235, 1988
63. JOHNSON RJ, ALPERS CE, PRUCHNO C, SCHULZE M, BAKER PJ, PRITZL P, COUSER WG: Mechanisms and kinetics for platelet and neutrophil localization in immune complex nephritis. Kidney Int 36:780-789, 1989
64. 2-halide system in immune complex nephritis. Kidney Int 32:342-349, 1987
65. YUZAWA Y, BRETT J, FUKATSU A, MATSUO S, CALDWELL PR, NIESEN N, MILGROM F, GODMAN G, STERN D, ANDRES G: Interaction of antibody with Forssman antigen in guinea pigs. A mechanism of adaptation to antibody- and complement-mediated injury. Am J Pathol 146:1260-1272, 1995
66. YUZAWA Y, BRENTJENS JR, BRETT J, CALDWELL PR, ESPOSITO C, FUKATSU A, GODMAN G, STERN D, ANDRES G: Antibody-mediated redistribution and shedding of endothelial antigens in the rabbit. J Immunol 150:5633-5646, 1993
67. PLATT JL: A perspective on xenograft rejection and accommodation. Immunol Rev 141:127-149, 1994
68. SIMS PJ, WIEDMER T: Induction of cellular procoagulant activity by the membrane attack complex of complement. Semin Cell Biol 6:275-282, 1995
69. BICK RL, MURANO G: Physiology of hemostasis. Clin Lab Med 4:677-707, 1994
70. BACH FH, ROBSON SC, FERRAN C, WINKLER H, MILLAN MT, STUHLMEIER KM, VANHOVE B, BLAKELY ML, VAN DER WERF WJ, HOFER E, DE MARTIN R, HANCOCK WW: Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 141:5-30, 1994
71. HATTORI R, HAMILTON KK, MCEVER RP, SIMS PJ: Complement proteins C5b-9 induces secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 264: 9053-9060, 1989
72. HAMILTON KK, HATTORI R, ESMON CT, SIMS PJ: Complement proteins C5b-9 induces vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 265:3809-3814, 1990
73. SAADI S, HOLZKNECHT RA, PATTE CP, STERN DM, PLATT JL: Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 182:1807-1814, 1995
74. Saadi S, Platt JL: Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med 181:21-31, 1995
75. PLATT JL, VERCELLOTTI GM, LINDMAN BJ, OEGEMA TR JR, BACH FH, DALMASSO AP: Release of heparan sulfate from endothelial cells: Implications for pathogenesis of hyperacute rejection. J Exp Med 171:1363-1368, 1990
76. FRAMPTON G, WALKER RG, PERRY GJ, HARADA T, CAMERON JS: IgA affinity to ssDNA or endothelial cells and its deposition in glomerular capillary walls in IgA nephropathy. Nephrol Dial Transplant 5:841-846, 1990
77. FORNASIERI A, PINEROLO C, BERNASCONI P, LI M, ARMELLONI S, GIBELLI A, D'AMICO G: Anti-mesangial and anti-endothelial cell antibodies in IgA mesangial nephropathy. Clin Nephrol 44:71-78, 1995
78. MCDONOGHUE DJ, FEEHALLY J: Autoantibodies in IgA nephropathy. Contrib Nephrol 111:93-103, 1995
79. YAP HK, SAKAI RS, BAHN L, RAPPAPORT V, WOO KT, ANANTHURMAN V, LIM CH, CHIANG GS, JORDAN JC: Antivascular endothelial cell antibodies in patients with IgA nephropathy: Frequency and clinical significance. Clin Immunol Immunopathol 49:450-462, 1988
80. KAIN R, MATSUI K, EXNER M, BINDER S, SCHAFFNER G, SOMMER EM, KERJASCHKI D: A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: The lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells. J Exp Med 181:585-597, 1995
81. ROSENBAUM J, POTTINGER BF, WOO P, BLACK CM, LOIZOU S, BYRON MA, PEARSON JD: Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 72:450-456, 1988
82. AMIGO M-C, GARCIA-TORRES R, ROBLES M, BOCHICCHIO T, REYES PA: Renal involvement in primary antiphospholipid syndrome. J Rheumatol 19:1181-1185, 1992
83. D'AGATI V, KUNIS C, WILLIAMS G, APPEL GB: Anti-cardiolipin antibody and renal disease: A report of three cases. J Am Soc Nephrol 1:777-784, 1990
84. BECQUEMONT L, THERVET E, RONDEAU E, LACAVE, R, MOUGENOT B, SRAER J-D: Systemic and renal fibrinolytic activity in a patient with anticardiolipin syndrome and renal thrombotic microangiopathy. Am J Nephrol 10:254-258, 1990
85. PIETTE J-C, CACOUB P, WECHSLER B: Renal manifestations of the antiphospholipid syndrome. Semin Arthr Rheum 23:357-366, 1994
86. HILL MB, PHIPPS JL, MALIA RG, GREAVES M, HUGHES P: Characterization and specificity of anti-endothelial cell membrane antibodies and their relationship to thrombosis in primary antiphospholipid syndrome (APS). Clin Exp Immunol 102:368-372, 1995
87. LINDSEY NJ, HENDERSON FI, MALIA R, MILFORD-WARD MA, GREAVES M, HUGHES P: Inhibition of prostacyclin release by endothelial binding anticardiolipin antibodies in thrombosis-prone patients with systemic lupus erythematosus and the antiphospholipid syndrome. Br J Rheumatol 33:20-26, 1994
88. CERVERA R, KHAMASHTA MA, FONT J, RAMÍREZ G, D'CRUZ D, MONTALBÁN J, LÓPEZ-SOTO A, ASHERSON RA, INGELMO M, HUGHES GR: Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity 11:1-6, 1991